A research team from the Anhui Institute of Optics and Fine Mechanics, the Hefei Institutes of Physical Science of the ...
Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and ...
A team of researchers from the Max Born Institute (MBI) in Berlin and DESY in Hamburg has demonstrated a plasma lens capable ...
November 3, 2025) - IR-MED Ltd. (OTCQB: IRME) (the "Company" or "IR-Med"), a pioneer in artificial intelligence ("AI")-driven, non-invasive infrared spectrographic medical device developer, today ...
Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, ...
DexCom, Inc. , the global leader in glucose biosensing, today announced the appointment of Euan Ashley to its Board of Directors, effective October 24, 2025. Dr. Ashley is a renowned researcher, ...
About BMF-650 BMF-650 is an investigational, next-generation oral small-molecule GLP-1 RA being developed by Biomea Fusion for the treatment of obesity. Related to the broader orforglipron chemotype, ...
Abstract: The transmission spectra of magnetic fluids with magnetite nanoparticles in kerosene with a solid phase concentration from 0.01% to 15% in the range of 350–1050 nm have been studied. At a ...
Abstract: Accurate identification of cloud phase in the Arctic is critical for evaluating surface energy budgets and reducing uncertainties in climate models, as clouds exert a complex, warming ...
Institute of Organic Chemistry and Biochemistry, Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback